LNSR · NASDAQ
LENSAR (LNSR) Stock Price & Fundamentals
LENSAR (LNSR) closed at $906.52 on Oct 9, 2026, up 1.64% from the previous close of $891.91.
Share price, past year
1Y +38.34%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $906.52 |
| Sep 30, 2026 | $895.09 |
| Aug 31, 2026 | $858.93 |
| Jul 31, 2026 | $829.66 |
| Jun 30, 2026 | $780.28 |
| May 29, 2026 | $773.09 |
| Apr 30, 2026 | $823.90 |
| Mar 31, 2026 | $773.04 |
| Feb 27, 2026 | $804.46 |
| Jan 30, 2026 | $746.12 |
| Dec 31, 2025 | $745.71 |
| Nov 28, 2025 | $685.90 |
| Oct 31, 2025 | $654.88 |
Key statistics
- Market cap
- $11.13B
- P/E (TTM)
- —
- EPS (TTM)
- −$0.30
- Revenue (TTM)
- $60.26M
- Net income (TTM)
- $34.70M
- Shares outstanding
- 12.3M
- Dividend yield
- —
- 52-week range
- $641.36 – $924.08
LENSAR's market cap is $11.13B, based on a share price of $906.52 and 12.3M shares outstanding as of Jun 30, 2026.
Financials
LENSAR reported revenue of $58.44M for fiscal 2025, up 9.24% from fiscal 2024.
LENSAR reported a net loss of $34.28M in fiscal 2025.
Fiscal 2025 revenue was the highest in the 7 years shown.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $58.44M | +9.2% | −$34.28M | −58.7% | −$2.87 | −$14.91M |
| FY2024ended Dec 31, 2024 | $53.49M | +26.9% | −$31.40M | −58.7% | −$2.73 | −$2.43M |
| FY2023ended Dec 31, 2023 | $42.16M | +19.3% | −$14.38M | −34.1% | −$1.31 | −$9.90M |
| FY2022ended Dec 31, 2022 | $35.36M | +2.6% | −$19.91M | −56.3% | −$1.96 | −$14.97M |
| FY2021ended Dec 31, 2021 | $34.46M | +30.6% | −$19.60M | −56.9% | −$2.09 | −$9.32M |
| FY2020ended Dec 31, 2020 | $26.38M | −13.6% | −$19.77M | −75.0% | −$4.28 | −$14.16M |
| FY2019ended Dec 31, 2019 | $30.53M | — | −$14.66M | −48.0% | −$13.70 | −$12.98M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $16.50M | $3.54M | $0.10 |
| Q1 FY2026ended Mar 31, 2026 | $13.43M | $36.33M | $0.00 |
| Q4 FY2025ended Dec 31, 2025 | $16.03M | −$1.46M | −$0.09 |
| Q3 FY2025ended Sep 30, 2025 | $14.32M | −$3.71M | −$0.31 |
| Q2 FY2025ended Jun 30, 2025 | $13.94M | −$1.76M | −$0.15 |
| Q1 FY2025ended Mar 31, 2025 | $14.16M | −$27.35M | −$2.32 |
| Q4 FY2024ended Dec 31, 2024 | $16.73M | −$18.70M | −$1.62 |
| Q3 FY2024ended Sep 30, 2024 | $13.54M | −$1.50M | −$0.13 |
Company profile
- Name
- LENSAR, Inc.
- Ticker
- LNSR
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Surgical & Medical Instruments & Apparatus
- Headquarters
- 2800 Discovery Drive, Suite 100, Orlando, FL 32826
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001320350
Recent SEC filings
- Aug 13, 2026
- Aug 13, 2026
- Aug 10, 2026
- May 29, 2026
- May 8, 2026
- May 8, 2026
- Apr 30, 2026
- Apr 15, 2026
Frequently asked questions
What is LENSAR's stock price?
LENSAR (LNSR) closed at $906.52 on Oct 9, 2026, up 1.64% from the previous close of $891.91.
What is LENSAR's market cap?
LENSAR's market cap is $11.13B, based on a share price of $906.52 and 12.3M shares outstanding as of Jun 30, 2026.
How much revenue does LENSAR make?
LENSAR reported revenue of $58.44M for fiscal 2025, up 9.24% from fiscal 2024.
Does LENSAR pay a dividend?
LENSAR's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from LENSAR, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures